ExodusPoint Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

ExodusPoint Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,645	Closed	-$353K	–	2445
2020 Q2	$353K	Buy	+19,645	New	+$273K	0.01%	1235
2020 Q1	–	Sell	-9,288	Closed	-$222K	–	1880
2019 Q4	$222K	Sell	9,288 -1,587	-15%	-$43.8K	﹤0.01%	1299
2019 Q3	$292K	Buy	+10,875	New	+$305K	0.01%	894

ExodusPoint Capital Management's PTLA Position: Q3 2020 in Review

ExodusPoint Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 19,645 shares — an estimated $353K sold.

ExodusPoint Capital Management first reported a position in PTLA in Q3 2019 and held it in 3 quarters. The position peaked at $353K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

ExodusPoint Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
ExodusPoint Capital Management sold 19,645 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $353K.
ExodusPoint Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 3 quarters.
ExodusPoint Capital Management's Portola Pharmaceuticals, Inc. position peaked at $353K in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.